William McKane

Epidemiology of and Diagnostic Strategies for Toxoplasmosis

Toxoplasmosis

Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

Biological roles of glycans

Natural Antibodies Against Sialoglycans

Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence

Sildenafil Citrate Treatment for Erectile Dysfunction After Kidney Transplantation

Trends in Incident Hemodialysis Access and Mortality

Aggregation-Induced Emission: Together We Shine, United We Soar!

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Characteristics of protein–carbohydrate interactions as a basis for developing novel carbohydrate‐based antirejection therapies

Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant

Randomized Trial of Trimethoprim-Sulfamethoxazole versus Pyrimethamine-Sulfadiazine for Therapy of Toxoplasmic Encephalitis in Patients with AIDS

KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update

Cotrimoxazole for Treatment of Cerebral Toxoplasmosis: An Observational Cohort Study during 1994–2006

De novo membranous nephropathy associated with donor‐specific alloantibody

Natural History of Proteinuria in Renal Transplant Recipients Developing De Novo Human Leukocyte Antigen Antibodies

Catheter access for hemodialysis defines higher mortality in late-presenting dialysis patients

Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil

Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis

POLYMORPHISM IN THE HUMAN ANTI-PIG NATURAL ANTIBODY REPERTOIRE